DE20022691U1 - Skin care products - Google Patents
Skin care productsInfo
- Publication number
- DE20022691U1 DE20022691U1 DE20022691U DE20022691U DE20022691U1 DE 20022691 U1 DE20022691 U1 DE 20022691U1 DE 20022691 U DE20022691 U DE 20022691U DE 20022691 U DE20022691 U DE 20022691U DE 20022691 U1 DE20022691 U1 DE 20022691U1
- Authority
- DE
- Germany
- Prior art keywords
- skin
- skin care
- care product
- adenosine
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000004166 Lanolin Substances 0.000 claims description 23
- 235000019388 lanolin Nutrition 0.000 claims description 23
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 13
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 229950006790 adenosine phosphate Drugs 0.000 claims description 12
- 239000002674 ointment Substances 0.000 claims description 12
- 229940039717 lanolin Drugs 0.000 claims description 11
- 239000006071 cream Substances 0.000 claims description 4
- QGXLVXZRPRRCRP-IDIVVRGQSA-L Adenosine 5'-phosphate disodium Chemical group [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O QGXLVXZRPRRCRP-IDIVVRGQSA-L 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 5
- OIRDTQYFTABQOQ-KQYNXXCUSA-N Adenosine Natural products C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 229960005305 adenosine Drugs 0.000 description 3
- -1 adenosine phosphates Chemical class 0.000 description 3
- 230000003716 rejuvenation Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000002431 foraging effect Effects 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- LNQVTSROQXJCDD-KQYNXXCUSA-N 3'-AMP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](OP(O)(O)=O)[C@H]1O LNQVTSROQXJCDD-KQYNXXCUSA-N 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- YLUGBQJQQLZZNL-UHFFFAOYSA-N O.O.O.O.O.O.O.[Na].[Na] Chemical compound O.O.O.O.O.O.O.[Na].[Na] YLUGBQJQQLZZNL-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000003835 adenosine derivatives Chemical class 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021324 borage oil Nutrition 0.000 description 1
- 239000010474 borage seed oil Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 229930012930 isoflavone derivative Natural products 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
&igr; ·&igr; ·
Die Erfindung betrifft ein Hautpflegemittel.The invention relates to a skin care product.
Es sind Hautpflegemittel bekannt, die meist die Hauptbestandteile Fett und Wasser aufweisen und damit die Haut vorläufig vor Austrocknung und schädlichen Umwelteinflüssen schüzen und ebenso gereizte Haut durch Ausgleichen des pH-Wertes der Haut beruhigen.There are skin care products that usually have the main ingredients of fat and water and thus temporarily protect the skin from drying out and harmful environmental influences and also soothe irritated skin by balancing the pH value of the skin.
In der DE 44 32 947 werden Isoflavonderivate in Mitteln zur Behandlung der Haut, u. a. zur Vorbeugung gegen Alterungsprozesse, beschrieben, wobei darauf hingewiesen wird, daß die in Sojaprodukten enthaltenen Isoflavonoide krebshemmende Wirkung aufweisen.In DE 44 32 947, isoflavone derivatives are described in products for treating the skin, including for preventing ageing processes, pointing out that the isoflavonoids contained in soy products have anti-cancer effects.
In der DE 44 31 251 wird eine Hautcreme u. a. für infolge von Alterungsprozessen trockene und empfindliche Haut beschrieben, deren günstiger Effekt wesentlich durch das enthaltene Sojalezithin hervorgerufen wird. Außerdem enthält die Hautcreme D, L-ct-Tokopherolacetat, ein Vitamin-E-Derivat, das ebenfalls gegen Hautalterung wirksam ist.DE 44 31 251 describes a skin cream for dry and sensitive skin as a result of aging processes, among other things, the beneficial effect of which is mainly due to the soya lecithin it contains. The skin cream also contains D, L-ct-tocopherol acetate, a vitamin E derivative that is also effective against skin aging.
In der DE 43 10 015 wird ein Mittel zur Pflege von trockener, empfindlicher Haut beschrieben, das als &ggr;-linolensäurehaltiges Pflanzenöl Borretschsamenöl und Soja-Phosphatidylcholin enthält.DE 43 10 015 describes a product for the care of dry, sensitive skin which contains borage seed oil and soy phosphatidylcholine as vegetable oil containing γ-linolenic acid.
Als linolensäurehaltiges Pflanzenöl bietet sich fur den Fachmann auch Sojaöl an, wie in SÖFW, 7/86, S. 225 bis 227 beschrieben.Soya oil is also a suitable vegetable oil containing linolenic acid, as described in SÖFW, 7/86, pp. 225 to 227.
Aus der DE 196 34 206 C 2 ist ein Hautpflegemittel, insbesondere für alternde Haut, auf Basis von Sojaöl und Sojalezithin bekannt, das 1 bis 10 Gew..-% Vitamin E und vorzugsweise 0,01 bis 0,10 Gew.-% Estradiol enthält. Dem Hautpflegemittel kann ein Duftstoff wie Lavendelöl zugesetzt werden. Ein anderer bevorzugter Zusatz sind Isoflavonide. Vorzugsweise liegt dieses bekannte Hautpflegemittel als Creme vor.DE 196 34 206 C 2 discloses a skin care product, particularly for aging skin, based on soy oil and soy lecithin, which contains 1 to 10% by weight of vitamin E and preferably 0.01 to 0.10% by weight of estradiol. A fragrance such as lavender oil can be added to the skin care product. Another preferred additive is isoflavones. This known skin care product is preferably in the form of a cream.
Die Verwendung von Adenosinphosphaten, wie Adenosin-tri-, -di- oder monophosphat, in kosmetischen Mitteln als Hautpflegemittel, insbesondere bei Hautrauhigkeit, ist beispielsweise aus JP 06128140 A und JP 03236320 A (Patent Abstracts of Japan) bekannt.The use of adenosine phosphates, such as adenosine tri-, di- or monophosphate, in cosmetic products as skin care products, in particular for rough skin, is known, for example, from JP 06128140 A and JP 03236320 A (Patent Abstracts of Japan).
In der Veröffentlichung von Orr, S. „Wollwachs: Emollient und Emulgator aus der Natur" in Parfümerie und Kosmetik, 79. Jg., Nr. 6/98, S. 14 - 17 wird die große Wasserabsorptionskapazität von Wollwachsalkohol-Emulsionen, insbesondere von Wollwachsalkohol-Vaseline-Mischungen, beschrieben (Seite 16), die bei der Anwendung auf der Haut zu einer#p.eduzierungjderJHautrauhigke#k führt (Seite 17).In the publication by Orr, S. "Wool wax: emollient and emulsifier from nature" in Parfümerie und Kosmetik, 79th year, no. 6/98, pp. 14 - 17, the high water absorption capacity of wool wax alcohol emulsions, in particular of wool wax alcohol-Vaseline mixtures, is described (page 16), which leads to a reduction in skin roughness when applied to the skin (page 17).
-2--2-
Der Erfindung liegt die Aufgabe zugrunde, ein Hautpflegemittel, insbesondere für alternde Haut bereitzustellen, das eine noch bessere Regeneration der Haut fördert als die zum Stand der Technik gehörenden, bekannten Hautpflegemittel und damit eine wirksamere Verjüngung der Haut bewirkt. Diese Aufgabe ist durch das in den Schutzansprüchen definierte Hautpflegemittel gelöst.The invention is based on the object of providing a skin care product, in particular for aging skin, which promotes even better regeneration of the skin than the known skin care products belonging to the prior art and thus brings about more effective rejuvenation of the skin. This object is achieved by the skin care product defined in the claims.
Gegenstand der Erfindung ist nun ein Hautpflegemittel, enthaltend 0,01 bis 10 Gew.-% Adenosinphosphat und 90 bis 99,99 Gew.-% Wollwachsalkoholsalbe.The invention now relates to a skin care product containing 0.01 to 10% by weight of adenosine phosphate and 90 to 99.99% by weight of wool wax alcohol ointment.
Bevorzugte Mischungsbereiche der Bestandteile Adenosinphosphat und Wollwachs-(Lanolin-) alkoholsalbe sind 0,1 bis 5 Gew.-% Adenosinphosphat und 99,9 bis 95 Gew.-% Wollwachs- (Lanolin-) alkoholsalbe.Preferred mixing ranges of the components adenosine phosphate and wool wax (lanolin) alcohol ointment are 0.1 to 5 wt.% adenosine phosphate and 99.9 to 95 wt.% wool wax (lanolin) alcohol ointment.
Noch weiter bevorzugt sind die Mischungsbereiche 0,2 bis 1 Gew.-% Adenosinphosphat und 99,8 bis 99 Gew.-% Wollwachs- (Lanolin-) alkoholsalbeEven more preferred are the mixture ranges 0.2 to 1 wt.% adenosine phosphate and 99.8 to 99 wt.% wool wax (lanolin) alcohol ointment
Ganz besonders bevorzugt werden Mischungsverhältnisse in der Gegend von 0,25 Gew.-% Adenosinphosphat und 99,75 Gew.-% Wollwachs- (Lanolin-) alkoholsalbe.Mixing ratios in the region of 0.25% by weight adenosine phosphate and 99.75% by weight wool wax (lanolin) alcohol ointment are particularly preferred.
Unter Adenosinphosphat wird hier vorzugsweise Adenosin-5'-monophosphat-Dinatrium (AMP) verstanden. Es sollen unter diesen Begriff im Zusammenhang mit der vorliegenden Erfindung aber auch Gemische fallen, die andere Adenosinderivate, wie Adenosin-3'-monophosphat, cyclisches Adenosinmonophosphat, Adenosin-• diphosphate oder -triphosphate, enthalten. Das Kation kann teilweise durch Kalium ersetzt sein.Adenosine phosphate is preferably understood here to mean adenosine 5'-monophosphate disodium (AMP). In connection with the present invention, however, this term also includes mixtures which contain other adenosine derivatives, such as adenosine 3'-monophosphate, cyclic adenosine monophosphate, adenosine diphosphates or triphosphates. The cation can be partially replaced by potassium.
Quantitativer Hauptbestandteil von kosmetischen Salben oder Cremes (diese Bezeichnungen werden im vorliegenden Zusammenhang als gleichwertig verwendet) ist im allgemeinen Vaseline, d. h. gelbes oder vorzugsweise weißes Paraffin (Petrolatum). Wollwachs (Lanolin)-alkohole (Lana alcoholum unguentum) sind Handelsprodukte und stellen die unverseifbaren Bestandteile des Lanolins dar. Weiterer gebräuchliche Nebenbestandteile von Salbengrundlagen sind Cetylstearylalkohole.The main quantitative component of cosmetic ointments or creams (these terms are used as equivalent in this context) is generally Vaseline, i.e. yellow or preferably white paraffin (petrolatum). Wool wax (lanolin) alcohols (Lana alcoholum unguentum) are commercial products and represent the unsaponifiable components of lanolin. Other common secondary components of ointment bases are cetylstearyl alcohols.
Das erfindungsgemäße Hautpflegemittel, das antipsoriatische Wirkung aufweist, kann als weitere Bestandteile übliche Zusätze von Salben, wie ätherische Öle, z. B. Jasmin-, Lavendel-, Sandelholz-, Ylang- oder Orangenöl, und/oder Harnstoff sowie Vitaminkombinationen enthalten.The skin care product according to the invention, which has an antipsoriatic effect, can contain as further components usual additives of ointments, such as essential oils, e.g. jasmine, lavender, sandalwood, ylang or orange oil, and/or urea as well as vitamin combinations.
Das neue Hautpflegemittel liegt vorzugsweise als Creme, beispielsweise als öl-in-Waser- oder Wasser-in-öl-Emulsion, oder Paste vor; andere dem Fachmann geläufige Anwendungsformen sind aber für die Zwecke der Erfindung ebenfalls geeignet.The new skin care product is preferably in the form of a cream, for example as an oil-in-water or water-in-oil emulsion, or paste; however, other application forms familiar to the person skilled in the art are also suitable for the purposes of the invention.
it ·&iacgr; · » ·* ■ r it ·í · » ·* ■ r
-3--3-
Die Erfindung beruht auf der überraschenden Feststellung, daß die Wirkung des neuen Hautpflegemittels eine Verjüngung der Haut zur Folge hat, die durch die bei der Anwendung ebenfalls erzielte Glättung der Haut unterstützt wird. Bei einer regelmäßigen Anwendung des erfindungsgemäßen Hautpflegemittels läßt sich innerhalb relativ kurzer Zeit eine Verjüngung der Haut feststellen. Die Hautfeuchtigkeit nimmt zu, und damit wird die Haut elastischer und fester, und die Fältchen der Haut glätten sich meßbar.The invention is based on the surprising discovery that the effect of the new skin care product results in a rejuvenation of the skin, which is supported by the smoothing of the skin that is also achieved during use. With regular use of the skin care product according to the invention, a rejuvenation of the skin can be observed within a relatively short period of time. The skin moisture increases, and thus the skin becomes more elastic and firmer, and the wrinkles on the skin are measurably smoothed out.
Nachfolgend wird die Erfindung an einem Beispiel näher beschrieben.The invention is described in more detail below using an example.
250 kg Wollwachsalkoholsalbe Pionier MAA (Zusammensetzung: 0,5 Gew.-Teile Cetylstearylalkohol, 6 Gew.-Teile Wollwachsalkohol und 93 Gew.-Teile weiße Vaseline) wurden auf 30 Grad C. erhitzt, und dann wurden 0,625 kg Adenosin-5-monophosphat-dinatrium-heptahydrat mit einem Rührwerk eingearbeitet. Die Mischung wurde bei leicht erhöhten Temperaturen homogenisiert, danach auf Raumtemperatur abgekühlt und in Dosen abgefüllt.250 kg of lanolin alcohol ointment Pionier MAA (composition: 0.5 parts by weight of cetylstearyl alcohol, 6 parts by weight of lanolin alcohol and 93 parts by weight of white Vaseline) were heated to 30 degrees C. and then 0.625 kg of adenosine-5-monophosphate disodium heptahydrate were incorporated using a stirrer. The mixture was homogenized at slightly elevated temperatures, then cooled to room temperature and filled into cans.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20022691U DE20022691U1 (en) | 2000-07-29 | 2000-07-29 | Skin care products |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE20022691U DE20022691U1 (en) | 2000-07-29 | 2000-07-29 | Skin care products |
| DE10036993 | 2000-07-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE20022691U1 true DE20022691U1 (en) | 2002-02-28 |
Family
ID=26006552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE20022691U Expired - Lifetime DE20022691U1 (en) | 2000-07-29 | 2000-07-29 | Skin care products |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE20022691U1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2847469A1 (en) * | 2002-11-26 | 2004-05-28 | Oreal | USE OF ADENOSINE OR AN ADENOSINE ANALOG FOR SMOOTHING EXPRESSION WRINKLES |
| EP2298275A4 (en) * | 2008-06-09 | 2013-12-18 | Otsuka Pharma Co Ltd | COMPOSITION FOR TOPICAL APPLICATION |
-
2000
- 2000-07-29 DE DE20022691U patent/DE20022691U1/en not_active Expired - Lifetime
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2847469A1 (en) * | 2002-11-26 | 2004-05-28 | Oreal | USE OF ADENOSINE OR AN ADENOSINE ANALOG FOR SMOOTHING EXPRESSION WRINKLES |
| EP1424064A1 (en) * | 2002-11-26 | 2004-06-02 | L'oreal | Use of adenosin or an adenosin analog to smooth out fine lines |
| EP2298275A4 (en) * | 2008-06-09 | 2013-12-18 | Otsuka Pharma Co Ltd | COMPOSITION FOR TOPICAL APPLICATION |
| EP3335693A1 (en) * | 2008-06-09 | 2018-06-20 | Otsuka Pharmaceutical Co., Ltd. | Composition for external use |
| US10966983B2 (en) | 2008-06-09 | 2021-04-06 | Otsuka Pharmaceutical Co., Ltd. | Composition for external use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69929837T2 (en) | Process for the removal of unpleasant volatile substances from lecithin | |
| DE2751128C2 (en) | Cosmetic emulsion and process for its preparation | |
| DE69706190T2 (en) | INNOVATIVE COMPOSITIONS BASED ON ALKYL GLYCOSIDES AND FATTY ALCOHOLS | |
| DE69515369T2 (en) | Surfactant-free water-in-oil emulsion | |
| DE69202827T2 (en) | Cosmetic preparations in the form of aqueous organopolysiloxane emulsions. | |
| DE145607T1 (en) | AQUEOUS OR WATER-FREE COSMETIC AGENT CONTAINING A FAT PHASE WITH KARITE OIL. | |
| DE69005918T2 (en) | Cosmetic preparation. | |
| DE69106630T2 (en) | Aqueous cosmetic composition and its manufacturing process. | |
| DE69831404T2 (en) | USE OF AT LEAST ONE IRVINGIA GABONENSIS EXTRACT IN COSMETIC AND / OR PHARMACEUTICAL PRODUCTS | |
| DE2300594C2 (en) | Skin treatment agents | |
| DE1030518B (en) | Skin care products | |
| DE4113346A1 (en) | Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease | |
| EP0065929B1 (en) | Process for the preparation of a cosmetic formulation | |
| DE20022691U1 (en) | Skin care products | |
| EP0008105B1 (en) | The use of citric acid esters in cosmetic preparations | |
| DE19634206C2 (en) | Skin care products, in particular for aging skin | |
| CH399655A (en) | Skin care products | |
| EP0604806A2 (en) | Composition containing phospholipids | |
| DE725292C (en) | Process for the production of ointment-like or paste-like emulsions | |
| DE69320638T2 (en) | TOPICAL AGENT | |
| DE2950917A1 (en) | WATER-IN-OIL TYPE EMULSIFIER | |
| DE566175C (en) | Ointment base or emulsifier | |
| DE3443737C2 (en) | ||
| DE545763C (en) | Process for the production of emulsions | |
| DE3407821A1 (en) | Hydrophilic derivative of natural beeswax, process for the preparation thereof, and compositions containing this derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R086 | Non-binding declaration of licensing interest | ||
| R207 | Utility model specification |
Effective date: 20020404 |
|
| R156 | Lapse of ip right after 3 years |
Effective date: 20040203 |